News & Articles
Novel research tackling challenges in women’s health announced at the 2021 AACC Annual Scientific Meeting
The latest discoveries show potential in resolving persistent challenges in healthcare and lab testing for women
Machine learning tools for COVID-19 patient screening and improved lab test management discussed at the 2021 AACC Annual Scientific Meeting
The new machine learning tool could help healthcare workers to quickly screen and direct the flow of COVID-19 patients arriving at hospitals
Queen’s University Belfast leads consortium to better understand link between healthy living and dementia
Can a healthy lifestyle combat undernutrition and dementia?
FDA takes steps aimed at improving quality, safety and efficacy of sunscreens
Today’s activities are part of ongoing implementation of new authorities for certain over-the-counter drugs
ELRIG UK launches equality, diversity, and inclusion guiding principles at Drug Discovery 2021
ELRIG’s EDI Guiding Principles promote inclusivity and collaboration in the drug discovery community
Chemomab Therapeutics collaborates with Leeds University to further elucidate the role of CCL24 in vascular damage
Chemomab’s CM-101 is a first-in-class, CCL24-neutralizing monoclonal antibody expected to enter a Phase 2 clinical trial in SSc patients early next year
The COVID-19 pandemic has caused the biggest decrease in life expectancy since World War II
A study by researchers at Oxford University found that we are amidst the biggest decrease in life expectancy since WWII
Assembly theory could spell good news for drug discovery
A new method of exploring chemical space could help create scientific breakthroughs in areas including drug design and discovery, its creators say.
The role of nanomaterials in electronics
In this article, Sanna Arpiainen, from the Graphene Flagship, looks at the role of layered materials in the future of electronics
AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity
AstraZeneca will invest in VaxEquity, an Imperial College spin-off
BD to invest $1.2 billion in pre-fillable syringe manufacturing over next four years Its investment includes a new manufacturing facility in Europe
Its investment includes a new manufacturing facility in Europe
Sequential photothermal flow chemistry delivers high yields of bicyclic lactams
Researchers at the University of Bristol have successfully prepared bicyclic lactams in high yield and excellent purity, using a photochemical [2+2] cycloaddition followed by a thermal electrocyclic cascade
Laser-etched bottom rack ID improves sample traceability
Micronic announces the addition of a 2D Data-Matrix code on the bottom of Micronic ULT Racks
Self-harm may be increasing more quickly among young people from ethnic minorities
The rates of self-harm could be rising more quickly in children and adolescents from ethnic minority groups than in those from white groups, according to a study led by University of Manchester researchers
Takara Bio Europe AB and Boston IVF Fertility Center announce partnership
The collaboration will enable the derivation of clinical-grade hES cell lines for cell therapy applications
University of Oxford and Oracle Cloud System helping researchers identify COVID-19 variants faster
The genomic sequencing platform facilitates the discovery and action of new, potentially harmful coronavirus mutations worldwide
Baby therapy boosts social development, reducing clinical autism diagnosis by two-thirds
These findings are the first evidence that a pre-emptive intervention during infancy could lead to a child falling below the threshold for a clinical diagnosis of autism
Astronomers solve 900-year-old cosmic mystery
Origins of 1181AD Chinese supernova have now been revealed
HORIBA scientific announces a new partnership with Covalent Metrology
North American Demo Lab will expand Covalent’s chemical analysis services and showcase HORIBA’s analytical instrumentation
Study links childhood exposure to air pollution and self-harm in later life
A study has revealed a link between higher levels of exposure to two common pollutants during childhood and an increased risk of self-harm in later life
GammaDelta Therapeutics initiates first-in-human Phase 1 trial of GDX012 for the treatment of acute myeloid leukemia
First dose delivered to patients in a multi-center U.S. clinical trial to evaluate novel gamma-delta T cell cancer therapy